US-APR2020

N/A

Report date: 2024/09/20 20:00:41

Base Information

Drug NameUS-APR2020
Drug Alias Namelive biotherapeutic (LBT)(Kibow Biotech)US-APR2020KT-301
ClassificationBiologics
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKibow Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKibow Biotech Inc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A